Insights from 2023 ESMO Annual Meeting

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Insights from 2023 ESMO Annual Meeting

Breast
Gastrointestinal
Genitourinary
Gynecologic
Skin
Sarcoma
Lung
Head and Neck
CNS

Playback speed

10 seconds

ESMO 2023 Insights: "Post Hoc Analysis of the CLEAR Trial - Tumor Response by Baseline Metastases in Patients With RCC Treated With Lenvatinib + Pembro vs. Sunitinib"

By Insights from 2023 ESMO Annual Meeting FEATURING Viktor Grünwald

119 views

October 25, 2023

Comments 0

Genitourinary

ESMO 2023 Insights: "PSMA PET-Directed Outcomes in mHSPC: Implicatio…

Insights from 2023 ESMO Annual Meeting

H. Abdel-Aty

100 views

ESMO 2023 Insights: "Prognostic Role of Metastatic Site in Patients …

Insights from 2023 ESMO Annual Meeting

E. Yekedüz

75 views

ESMO 2023 Insights: "Association of Health-Related Quality of Life w…

Insights from 2023 ESMO Annual Meeting

M. Morris

55 views

ESMO 2023 Insights: "Vascular Fingerprint Tool to Identify Testicula…

Insights from 2023 ESMO Annual Meeting

A. Meuleman

26 views

ESMO 2023 Insights: "Real-World OS With Enzalutamide & Abiraterone A…

Insights from 2023 ESMO Annual Meeting

D. George

108 views

ESMO 2023 Insights: "ARASENS Trial - PSA Outcomes With Darolutamide,…

Insights from 2023 ESMO Annual Meeting

F. Saad

115 views

ESMO23 Highlights in Urothelial Carcinoma

Insights from 2023 ESMO Annual Meeting

G. Sonpavde, B. McGregor

243 views

ESMO 2023 Insights: "The BonEnza Study - Changes in Bone Mineral Den…

Insights from 2023 ESMO Annual Meeting

A. Dalla Volta

87 views

ESMO 2023 Insights: "MEDI5752 (Volrustomig) in the 1L Treatment of P…

Insights from 2023 ESMO Annual Meeting

M. Voss

132 views

ESMO 2023 Insights: "Efficacy & Safety Outcomes With Pembro Rechalle…

Insights from 2023 ESMO Annual Meeting

V. Koshkin

188 views

ESMO 2023 Insights: "Bladder Preservation Strategies - A Surgeon’s P…

Insights from 2023 ESMO Annual Meeting

J. Boormans

91 views

ESMO 2023 Insights: "EMBARK Secondary Endpoints - Enzalutamide Monot…

Insights from 2023 ESMO Annual Meeting

U. De Giorgi

281 views

ESMO 2023 Insights: "The DAD Trial - SG+EV as ≥ 2L Therapy for mUC"

Insights from 2023 ESMO Annual Meeting

B. McGregor

174 views

ESMO 2023 Insights: "State-of-the-Art in Adjuvant Treatment of RCC"

Insights from 2023 ESMO Annual Meeting

G. de Velasco

312 views

ESMO 2023 Insights: "[177 Lu]Lu-PSMA-617 in Taxane-Naïve Patients Wi…

Insights from 2023 ESMO Annual Meeting

O. Sartor

345 views

ESMO 2023 Insights: "THOR Study - Erdafitinib vs. Pembrolizumab in P…

Insights from 2023 ESMO Annual Meeting

A. Siefker-Radtke

174 views

ESMO 2023 Insights: "The Tide-A Study - Avelumab + Intermittent Axit…

Insights from 2023 ESMO Annual Meeting

R. Iacovelli

96 views

ESMO 2023 Insights: "CABASTY Trial - Pain Response and HRQL Analysis…

Insights from 2023 ESMO Annual Meeting

S. Oudard

118 views

ESMO 2023 Insights: "EV-302/KEYNOTE-A39 Study of Enfortumab Vedotin …

Insights from 2023 ESMO Annual Meeting

T. Powles

300 views

Bladder Cancer Highlights From ESMO 2023: Comparing and Contrasting …

Insights from 2023 ESMO Annual Meeting

G. Sonpavde

853 views

ESMO 2023 Insights: "Effect of Rapid Ultra-Low Prostate-Specific Ant…

Insights from 2023 ESMO Annual Meeting

A. Merseburger

460 views

ESMO 2023 Insights: "Androgen Receptor Pathway Inhibitors or Taxanes…

Insights from 2023 ESMO Annual Meeting

H. Grönberg

86 views

ESMO 2023 Insights: "Post Hoc Analysis of the CLEAR Trial - Tumor Re…

Insights from 2023 ESMO Annual Meeting

V. Grünwald

119 views

ESMO 2023 Insights: "Phase 3 Randomized EMBARK Study - Enzalutamide/…

Insights from 2023 ESMO Annual Meeting

S. Freedland

509 views

ESMO 2023 Insights: "LITESPARK-005 Study - Belzutifan vs. Everolimus…

Insights from 2023 ESMO Annual Meeting

L. Albiges

145 views